משטר מינון: מינון קבוע

Multiple fixed doses maintain safe and therapeutic drug levels in the body by counteracting elimination. When the first dose is administered, plasma concentration peaks then declines due to elimination. The next dose is given when concentration falls to 50% of the starting value, raising levels again. This repetitive cycle allows the body to accumulate drug until steady state is achieved, where administration rate equals elimination rate.

Steady state occurs when the rate of drug administration equals the rate of elimination, resulting in consistent drug concentration in the bloodstream. At this point, drug levels remain within the therapeutic range, avoiding excessive fluctuations. Steady state is achieved through repetitive dosing cycles that allow the body to accumulate the drug to optimal levels for effective and lasting therapeutic response.

Intravenous fixed-dose regimens involve injecting a predetermined amount of drug directly into veins at specific intervals. Oral fixed-dose regimens require taking tablets or capsules at designated times throughout the day. Both routes use the same principle of administering specific amounts at regular intervals to maintain consistent drug concentration, though the delivery method and absorption pathways differ.

Plasma concentration peaks immediately after each dose is administered, then declines due to elimination until the next dose is given. This creates a cyclical pattern where concentration rises and falls within a therapeutic range. A well-designed fixed-dose regimen prevents excessive fluctuations, ensuring the drug remains effective while minimizing the risk of adverse effects from concentration spikes or drops.

Fixed-dose regimens simplify treatment by providing patients with a structured schedule for medication administration. Patients follow consistent dosing intervals, such as taking a pill three times daily or receiving injections twice daily, which enhances adherence. This predictable approach avoids the complexities of continuous infusions or variable dosing, making it practical and convenient for patients to maintain therapeutic outcomes.

Drug elimination determines when plasma concentration falls to 50% of the starting value, triggering the next dose. The elimination rate directly influences dosing intervals—faster elimination requires more frequent doses, while slower elimination allows longer intervals. Understanding elimination kinetics is essential for designing fixed-dose regimens that maintain therapeutic levels and achieve steady state efficiently.

The therapeutic range is the concentration window where a drug is both safe and effective. Fixed-dose regimens are designed to keep drug levels within this range by avoiding excessive fluctuations. Concentrations below the range lack efficacy, while concentrations above it risk adverse effects. A well-designed regimen ensures the drug generates an effective and lasting response while minimizing toxicity and side effects.